JP2016506923A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016506923A5 JP2016506923A5 JP2015554285A JP2015554285A JP2016506923A5 JP 2016506923 A5 JP2016506923 A5 JP 2016506923A5 JP 2015554285 A JP2015554285 A JP 2015554285A JP 2015554285 A JP2015554285 A JP 2015554285A JP 2016506923 A5 JP2016506923 A5 JP 2016506923A5
- Authority
- JP
- Japan
- Prior art keywords
- mir
- seq
- sequence
- nucleotide identity
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13305082.3 | 2013-01-24 | ||
| EP13305082.3A EP2759595B1 (en) | 2013-01-24 | 2013-01-24 | Composition comprising an encapsulated antagomir |
| PCT/IB2014/058500 WO2014115103A1 (en) | 2013-01-24 | 2014-01-23 | Composition comprising an encapsulated antagomir |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016506923A JP2016506923A (ja) | 2016-03-07 |
| JP2016506923A5 true JP2016506923A5 (https=) | 2017-02-02 |
Family
ID=47683670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015554285A Pending JP2016506923A (ja) | 2013-01-24 | 2014-01-23 | カプセル化アンタゴｍｉｒを含む組成物 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20150352055A1 (https=) |
| EP (2) | EP2759595B1 (https=) |
| JP (1) | JP2016506923A (https=) |
| KR (1) | KR20160018451A (https=) |
| CN (1) | CN105229151A (https=) |
| AU (1) | AU2014208419A1 (https=) |
| BR (1) | BR112015017650A2 (https=) |
| CA (1) | CA2898958A1 (https=) |
| ES (2) | ES2606636T3 (https=) |
| HK (1) | HK1219753A1 (https=) |
| HU (1) | HUE032125T2 (https=) |
| MX (1) | MX2015009323A (https=) |
| PL (1) | PL2759595T3 (https=) |
| RU (1) | RU2668794C2 (https=) |
| WO (1) | WO2014115103A1 (https=) |
| ZA (1) | ZA201505602B (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9388408B2 (en) | 2012-06-21 | 2016-07-12 | MiRagen Therapeutics, Inc. | Oligonucleotide-based inhibitors comprising locked nucleic acid motif |
| US9885042B2 (en) | 2015-01-20 | 2018-02-06 | MiRagen Therapeutics, Inc. | miR-92 inhibitors and uses thereof |
| EP3601565A4 (en) * | 2017-03-25 | 2021-01-06 | Miragen Therapeutics, Inc. | MIR-92 INHIBITORS IN THE TREATMENT OF HEART FAILURE |
| CN113490488A (zh) * | 2019-03-14 | 2021-10-08 | M技术株式会社 | Plga微粒子、其缓释制剂以及其制造方法 |
| CN110484537B (zh) * | 2019-09-02 | 2021-07-27 | 中国水产科学研究院淡水渔业研究中心 | 一种miR-92促进剂及其注射剂的制备方法和应用 |
| CN110804659B (zh) * | 2019-10-23 | 2023-02-03 | 华南农业大学 | 一种血清外泌体ssc-miR-92b-3p作为母猪早期妊娠诊断分子标志物的应用 |
| CN110917359A (zh) * | 2019-11-21 | 2020-03-27 | 武汉理工大学 | 离子键自组装制备PEG-P（Asp-AP）-ANTAGOMIR-RNA微球 |
| WO2021251526A1 (ko) * | 2020-06-11 | 2021-12-16 | 주식회사 프로스테믹스 | 신규한 mirna 유사체 및 이의 용도 |
| CN111729088B (zh) * | 2020-08-21 | 2020-12-15 | 江苏申基生物科技有限公司 | 一种微小核糖核酸miR-34a偶联探针及其制备方法 |
| WO2025050037A1 (en) * | 2023-08-31 | 2025-03-06 | The Regents Of The University Of Colorado, A Body Corporate | Microrna-15b antagomir and cerium oxide nanoparticles, and uses of same for treatment of intrauterine growth restriction |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8383158B2 (en) * | 2003-04-15 | 2013-02-26 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
| US7683036B2 (en) * | 2003-07-31 | 2010-03-23 | Regulus Therapeutics Inc. | Oligomeric compounds and compositions for use in modulation of small non-coding RNAs |
| EP2623599B1 (en) * | 2007-10-04 | 2019-01-02 | Roche Innovation Center Copenhagen A/S | Micromirs |
| DE102007052114B4 (de) * | 2007-10-30 | 2011-01-05 | T2Cure Gmbh | Verfahren zur Modulation der Funktion, des Wachstums oder der Differenzierung einer Zelle |
| GB0814302D0 (en) * | 2008-08-05 | 2008-10-01 | Coretherapix Slu | Compounds and methods |
| US9072765B2 (en) * | 2009-05-20 | 2015-07-07 | Board Of Regents, The University Of Texas System | Identification of micro-RNAs involved in post-myocardial infarction remodeling and heart failure |
-
2013
- 2013-01-24 ES ES13305082.3T patent/ES2606636T3/es active Active
- 2013-01-24 HU HUE13305082A patent/HUE032125T2/en unknown
- 2013-01-24 PL PL13305082T patent/PL2759595T3/pl unknown
- 2013-01-24 EP EP13305082.3A patent/EP2759595B1/en not_active Not-in-force
-
2014
- 2014-01-23 MX MX2015009323A patent/MX2015009323A/es unknown
- 2014-01-23 BR BR112015017650A patent/BR112015017650A2/pt not_active IP Right Cessation
- 2014-01-23 KR KR1020157022914A patent/KR20160018451A/ko not_active Withdrawn
- 2014-01-23 AU AU2014208419A patent/AU2014208419A1/en not_active Abandoned
- 2014-01-23 US US14/763,181 patent/US20150352055A1/en not_active Abandoned
- 2014-01-23 CN CN201480017728.3A patent/CN105229151A/zh active Pending
- 2014-01-23 RU RU2015134770A patent/RU2668794C2/ru not_active IP Right Cessation
- 2014-01-23 HK HK16107653.5A patent/HK1219753A1/zh unknown
- 2014-01-23 EP EP14706098.2A patent/EP2948551B1/en not_active Not-in-force
- 2014-01-23 CA CA2898958A patent/CA2898958A1/en not_active Abandoned
- 2014-01-23 ES ES14706098.2T patent/ES2688160T3/es active Active
- 2014-01-23 WO PCT/IB2014/058500 patent/WO2014115103A1/en not_active Ceased
- 2014-01-23 JP JP2015554285A patent/JP2016506923A/ja active Pending
-
2015
- 2015-08-04 ZA ZA2015/05602A patent/ZA201505602B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016506923A5 (https=) | ||
| RU2015134770A (ru) | Композиция, содержащая инкапсулированный антагомир | |
| Sethi et al. | Regulating miRNA by natural agents as a new strategy for cancer treatment | |
| Park et al. | Antisense inhibition of microRNA-21 or-221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma | |
| CN104053775B (zh) | 用于治疗缺血性损伤的化合物 | |
| RU2011151991A (ru) | Идентификация микро-рнк, учавствующих в постинфарктном ремоделировании и сердечной недостаточности | |
| Hernando | microRNAs and cancer: role in tumorigenesis, patient classification and therapy | |
| JP2015521626A5 (https=) | ||
| HRP20201200T1 (hr) | OLIGONUKLEOTIDNI SPOJEVI ZA CILJANJE HUNTINGTIN mRNK | |
| BRPI0811170B8 (pt) | oligonucleotídeos de rna e complexos de rna substituídos por hidroximetila | |
| MX2013005875A (es) | Inhibidores de microarn que comprenden nucleotidos bloqueados. | |
| JP2017528441A5 (https=) | ||
| Ishimoto et al. | Current perspectives toward the identification of key players in gastric cancer micro RNA dysregulation | |
| JP2018530530A5 (https=) | ||
| WO2013157010A1 (en) | Methods and compositions for rnai-based cancer treatment | |
| EA201590070A1 (ru) | ИНГИБИТОРЫ МИКРОРНК СЕМЕЙСТВА miR-15 | |
| Liu et al. | MicroRNA as regulators of cancer stem cells and chemoresistance in colorectal cancer | |
| Mocellin et al. | Oncomirs: from tumor biology to molecularly targeted anticancer strategies | |
| CN108350456A (zh) | 治疗性寡核苷酸 | |
| JP2017527775A5 (https=) | ||
| Karkhane et al. | Oncogenesis and tumor inhibition by microRNAs and its potential therapeutic applications: a systematic review | |
| JP2020512819A (ja) | 骨量減少または筋機能低下に関連する病的状態を治療する際に使用するためのマイクロｒｎａ１９ａ／１９ｂ | |
| Nancy et al. | RNA as a Target for Cancer Treatment | |
| Dabelić et al. | Silencing of HSP90 affects miRNA profile in monocyte-like cells | |
| Ling et al. | MicroRNAs as Drugs and Drug Targets in Cancer |